Analysts predict that Medical Transcription Billing Corp (NASDAQ:MTBC) will report sales of $16.66 million for the current quarter, according to Zacks. Two analysts have made estimates for Medical Transcription Billing’s earnings, with the highest sales estimate coming in at $17.00 million and the lowest estimate coming in at $16.31 million. Medical Transcription Billing reported sales of $7.51 million in the same quarter last year, which indicates a positive year-over-year growth rate of 121.8%. The company is scheduled to issue its next earnings report on Monday, November 5th.

On average, analysts expect that Medical Transcription Billing will report full year sales of $49.43 million for the current fiscal year, with estimates ranging from $49.00 million to $50.00 million. For the next financial year, analysts anticipate that the company will post sales of $65.20 million per share, with estimates ranging from $63.00 million to $68.61 million. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that cover Medical Transcription Billing.

Medical Transcription Billing (NASDAQ:MTBC) last issued its earnings results on Wednesday, August 8th. The technology company reported ($0.09) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.09). Medical Transcription Billing had a negative net margin of 2.73% and a positive return on equity of 2.01%. The business had revenue of $8.68 million for the quarter, compared to the consensus estimate of $8.39 million.

Separately, HC Wainwright set a $6.00 target price on shares of Medical Transcription Billing and gave the company a “buy” rating in a research note on Monday, August 13th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $3.92.

In related news, CFO Bill Korn sold 5,000 shares of Medical Transcription Billing stock in a transaction on Wednesday, July 25th. The shares were sold at an average price of $5.01, for a total transaction of $25,050.00. Following the sale, the chief financial officer now owns 152,800 shares of the company’s stock, valued at approximately $765,528. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, General Counsel Shruti H. Patel sold 12,291 shares of Medical Transcription Billing stock in a transaction on Wednesday, September 12th. The stock was sold at an average price of $4.61, for a total transaction of $56,661.51. The disclosure for this sale can be found here. Insiders have sold a total of 27,491 shares of company stock worth $129,712 in the last ninety days. 49.70% of the stock is currently owned by insiders.

An institutional investor recently bought a new position in Medical Transcription Billing stock. Dimensional Fund Advisors LP purchased a new position in shares of Medical Transcription Billing Corp (NASDAQ:MTBC) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 27,909 shares of the technology company’s stock, valued at approximately $108,000. Dimensional Fund Advisors LP owned 0.24% of Medical Transcription Billing at the end of the most recent reporting period. 5.84% of the stock is owned by hedge funds and other institutional investors.

Shares of MTBC stock traded up $0.08 during mid-day trading on Thursday, reaching $4.53. The company’s stock had a trading volume of 89,994 shares, compared to its average volume of 120,975. Medical Transcription Billing has a 12-month low of $1.40 and a 12-month high of $5.44.

Medical Transcription Billing Company Profile

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Read More: How to Invest in an Index Fund

Get a free copy of the Zacks research report on Medical Transcription Billing (MTBC)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with's FREE daily email newsletter.